← Back to Search

Continuous Glucose Monitor

Dexcom G6 Continuous Glucose Monitor for Type 1 Diabetes (IMPaCT Trial)

N/A
Waitlist Available
Led By Risa Wolf, MD
Research Sponsored by Johns Hopkins University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Diagnosis of Type 1 diabetes for >3 months
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3-6 months
Awards & highlights

IMPaCT Trial Summary

This study is evaluating whether a continuous glucose monitor may help improve glucose control in children with type 1 diabetes.

Eligible Conditions
  • Type 1 Diabetes
  • Low Blood Sugar
  • High Blood Sugar

IMPaCT Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

IMPaCT Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3-6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3-6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in Personal CGM Use
Secondary outcome measures
Change in Hemoglobin A1c
Change in the Percent Time in Range Glucose Control
Using Personal CGM

IMPaCT Trial Design

1Treatment groups
Experimental Treatment
Group I: Dexcom G6 Continuous Glucose MonitorExperimental Treatment1 Intervention
Children with type 1 diabetes will wear a continuous glucose monitor (CGM) for 10 days.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Dexcom G6 Continuous Glucose Monitor
2021
N/A
~30

Find a Location

Who is running the clinical trial?

DexCom, Inc.Industry Sponsor
137 Previous Clinical Trials
29,826 Total Patients Enrolled
Johns Hopkins UniversityLead Sponsor
2,262 Previous Clinical Trials
14,823,138 Total Patients Enrolled
Risa Wolf, MDPrincipal InvestigatorJohns Hopkins University
1 Previous Clinical Trials
164 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
CGM Use in Poorly Controlled Youth With Type 1 Diabetes
2021. "CGM Use in Poorly Controlled Youth With Type 1 Diabetes". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04721145.
~6 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top